文献速递银屑病与炎症性皮肤病

银屑病与帕金森病进展:一项孟德尔随机化研究

Psoriasis and progression of Parkinson's disease: a Mendelian randomization study.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2022-08-09

研究采用两样本孟德尔随机化分析,利用银屑病(N=33394)、帕金森病发病年龄(N=28568)和进展(N=4093)的全基因组关联研究汇总数据,评估银屑病对帕金森病进展的因果作用。结果显示遗传决定的银屑病风险每增加一个标准差与更快进展至痴呆显著相关(OR=1.07,95%CI:0.1.03-1.1,P=4.71E-04),与更快进展至Hoehn和Yahr 3期(OR=1.05,95%CI:1.02-1.08,P=1.53E-03)及抑郁(OR=1.06,95%CI:1.02-1.11,P=1.77E-03)名义相关。结论提示银屑病加速帕金森病整体进展,并增加帕金森病痴呆和抑郁风险。

要点

  • 遗传决定的银屑病风险每增加一个标准差与更快进展至痴呆显著相关(OR=1.07)。
  • 银屑病风险较高与更快进展至Hoehn和Yahr 3期名义相关(OR=1.05)。
  • 银屑病风险较高与更快进展至抑郁名义相关(OR=1.06)。

核心结论

  • 结果提示银屑病加速帕金森病整体进展,并增加帕金森病痴呆和抑郁风险。
  • 更深入理解神经炎症和免疫反应可能有助于阐明帕金森病进展的潜在发病机制并识别新的治疗靶点。

研究设计与样本

  • 采用两样本孟德尔随机化分析,使用银屑病(N=33394)、帕金森病发病年龄(N=28568)和进展(N=4093)的全基因组关联研究汇总数据。

主要发现

  • 遗传决定的银屑病风险每增加一个标准差与更快进展至痴呆显著相关(OR=1.07,95%CI:0.1.03-1.1,P=4.71E-04)。
  • 银屑病风险较高与以进展至Hoehn和Yahr 3期时间衡量的帕金森病更快进展名义相关(OR=1.05,95%CI:1.02-1.08,P=1.53E-03)。
  • 银屑病风险较高与帕金森病抑郁更快进展名义相关(OR=1.06,95%CI:1.02-1.11,P=1.77E-03)。
  • 结果在所有敏感性分析下均稳健。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epidemiological studies have suggested psoriasis was associated with an increased risk of Parkinson's disease (PD). However, whether psoriasis has an effect on PD progression is not explored yet. OBJECTIVES: To evaluate the causal role of psoriasis in PD progression. METHODS: We conducted a two-sample Mendelian randomization analysis using summary statistics from genome-wide association study of psoriasis (N = 33 394), age at onset (N = 28 568) and progression (N = 4093) of PD. RESULTS: One standard deviation increase in genetically determined psoriasis risk was significantly associated with faster progression to dementia (OR = 1.07, 95% CI: 0.1.03-1.1, P = 4.71E-04). Meanwhile, higher psoriasis risk was nominally associated with faster progression of PD measured by time to Hoehn and Yahr stage 3 (OR = 1.05, 95% CI: 1.02-1.08, P = 1.53E-03) and depression (OR = 1.06, 95% CI: 1.02-1.11, P = 1.77E-03) of PD. The results were robust under all sensitivity analyses. CONCLUSIONS: These results suggested psoriasis accelerated overall progression of PD, and increased risk of dementia and depression of PD. A deeper understanding of neuroinflammation and immune response is likely to elucidate the potential pathogenesis of PD progression and identify novel therapeutic targets.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Li C, Li X, Lin J, et al. Psoriasis and progression of Parkinson's disease: a Mendelian randomization study. J Eur Acad Dermatol Venereol. 2022. PMID: 35870136. doi:10.1111/jdv.18459

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。